The cystic fibrosis transmembrane conductance regulator (CFTR), a member of the traffic ATPase superfamily, possesses two putative nudeotide-binding folds (NBFs). The NBFs are sufficiently similar that sequence alignment of highly conserved regions can be used to identify analogous residues in the two domains. To determine whether this structural homology is paralleled in function, we compared the activation of chloride conductance by forskolin and 3-isobutyl-l-methylxanthine in Xenopus oocytes expressing CFTRs bearing mutations in NBF1 or NBF2. Mutation of a conserved glycine in the putative linker domain in either NBF produced virtually identical changes in the sensitivity of chloride conductance to activating conditions, and mutation of this site in both NBFs produced additive effects, suggesting that in the two NBFs this region plays a similar and critical role in the activation process. In contrast, amino acid substitutions in the Walker A and B motifs, thought to form an integral part of the nucleotide-binding pockets, produced strikingly different effects in NBF1 and NBF2. Substitutions for the conserved lysine (Walker A) or aspartate (Walker B) in NBF1 resulted in a marked decrease in sensitivity to activation, whereas the same changes in NBF2 produced an increase in sensitivity. These results are consistent with a model for the activation of CFTR in which both NBF1 and NBF2 are required for normal function but in which either the nature or the exact consequences of nucleotide binding differ for the two domains.
3-isobutyl-l-methylxanthine in Xenopus oocytes expressing
CFTRs bearing mutations in NBF1 or NBF2. Mutation of a conserved glycine in the putative linker domain in either NBF produced virtually identical changes in the sensitivity of chloride conductance to activating conditions, and mutation of this site in both NBFs produced additive effects, suggesting that in the two NBFs this region plays a similar and critical role in the activation process. In contrast, amino acid substitutions in the Walker A and B motifs, thought to form an integral part of the nucleotide-binding pockets, produced strikingly different effects in NBF1 and NBF2. Substitutions for the conserved lysine (Walker A) or aspartate (Walker B) in NBF1 resulted in a marked decrease in sensitivity to activation, whereas the same changes in NBF2 produced an increase in sensitivity. These results are consistent with a model for the activation of CFTR in which both NBF1 and NBF2 are required for normal function but in which either the nature or the exact consequences of nucleotide binding differ for the two domains.
Cystic fibrosis (CF) is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR). Homology analysis revealed that CFTR is a member of a superfamily of proteins referred to as traffic ATPases (1) or ATP binding cassette (ABC) proteins (2, 3) that includes various prokaryotic permeases as well as eukaryotic proteins such as P-glycoprotein (4, 5) . A consistent feature of this family is the presence of hydrophilic domains having amino acid sequences characteristic of mononucleotide-binding proteins. CFTR has two putative nucleotidebinding folds (NBFs) (6) , and the amino acid sequences are shown aligned in Fig. 1 . Each predicted NBF contains three sequence motifs that are well conserved across the traffic ATPase superfamily. Two of these motifs, Walker A and B (7) , are thought to form a portion of a nucleotide-binding pocket. The conserved lysine in Walker A is predicted to interact with the phosphoryl moiety of the bound nucleotide (8, 9) and the aspartic acid in Walker B to coordinate Mg2+ of the MgATP complex (10, 11 pocket to other domains of the protein (12, 13) . The importance of this putative linker motif to CFTR function is evidenced by the seven CF missense mutations reported within this region of NBF1 and NBF2 (14) .
In a variety of cells expressing CFTR, experimental maneuvers that elevate cytosolic cAMP activate a Cl--selective conductance (gc) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) , and it is now generally accepted that CFTR functions as a Cl--selective ion channel (17, 25) gated by cAMP-dependent protein kinase (PKA) and ATP (19, (26) (27) (28) (29) paralleled by reduced sensitivity to injected cAMP or catalytic subunit of PKA (30) .
The purpose of the present study was to examine the functional consequences of corresponding mutations in NBF1 and NBF2 of CFTR by comparing the effects of these mutations on the sensitivity of Cl-conductance to activation by forskolin and IBMX. The Xenopus oocyte expression system offered two potential advantages: (i) dose-dependent activation permitted a direct, quantitative comparison of the sensitivities of CFTR variants and (ii) mutant CFTR protein appears less likely to be subject to intracellular processing problems in oocytes than in other cell types. For example, AF508, a mutant that exhibits a severe processing defect at 37°C in mammalian cells (31) (32) (33) , is associated with a robust cAMP-activated Cl-conductance in oocytes (18) . The results obtained with this expression system are consistent with the idea that both NBFs are required for normal activation of CFTR, but suggest that the two domains function differently in this process.
MATERIALS AND METHODS
In Vitro Mutagenesis Procedures, Plasmid Construction, and RNA Synthesis. To generate the mutation constructs, a 1.7-kb (includes NBF1 Walker A) and a 3.0-kb (includes G551, NBF1 Walker B, and NBF2) Sph I-Sac I CFTR cDNA fragment were cloned into pSelect vector (Promega). Oligonucleotide-mediated site-directed mutagenesis was performed (Altered Sites manual, Promega) using oligonucleotides corresponding to the desired mutations. The mutated fragments were transferred into a full-length CFTR cDNA construct (23) in pBluescript (Stratagene) and the presence of the mutations was verified by sequencing. The full-length constructs contained a valine-for-methionine substitution at amino acid 1475 (V1475M). This substitution does not affect the sensitivity of CFTR to forskolin and IBMX (unpublished data). RNA was synthesized by in vitro transcription (18) .
Oocytes and RNA Injection. Female toads (Xenopus laevis)
were anesthetized by immersion in ice water containing 3-aminobenzoic acid ethyl ester (2 mg/ml; Sigma), and oocytes were removed via a small abdominal incision. The follicular membranes were removed by blunt dissection after incubation for 2-6 hr in a nominally Ca2+-free solution containing collagenase (2.5 mg/ml; GIBCO). Defolliculated oocytes were injected with 0.1-15 ng of RNA in 50 nl of diethyl pyrocarbonate-treated water.
Two-Electrode Voltage Clamp. Oocytes injected 3-6 days previously were placed in a perfusion chamber, impaled with two electrodes, and voltage clamped (TEV-200; Dagen Instruments, Minneapolis). The perfusion solution was an amphibian Ringer's solution containing 100.5 mM Na+, 2 mM K+, 1.8 mM Ca2+, 1 mM Mg2+, 105.6 mM Cl-, and 5 mM Hepes. Membrane currents were assayed at a holding potential of 60 mV, inside negative, and the CFTR-mediated current was defined as that activated by a stimulatory cocktail containing 10 AM forskolin and 0.02-5 mM IBMX.
Membrane currents in uninjected or water-injected oocytes were typically unresponsive, whereas oocytes expressing CFTR variants exhibited quasi-steady-state inward currents with maximum values ranging from 200 nA to several microamperes. Current-voltage records were acquired by means of a computer-generated ramp command that changed the holding potential from -120 mV to +40 mV at a rate of 100 mV/sec. These records were corrected for a small component of capacitative current. Membrane conductances were calculated from the slopes of the current-voltage relations between -50 and -70 mV. IBMX dose-response relationships were determined as described in the legend to Fig. 2 [2] [3] [4] [5] . The greatest source of variability in determination of the normalized IBMX dose-response was the difficulty in estimating the true value of the maximum cAMPinduced Cl-conductance in oocytes expressing high levels of activatable CFTR. For this reason, expression levels for easily activated constructs (wild type, G551A, G1349A, K1250Q, and D1370N) were adjusted by reducing the amount of injected RNA so that the maximum Cl-conductance was similar to that attained by less sensitive constructs. The IBMX dose-response relationships presented here were constructed from experiments in which the maximum stimulated Cl-conductance was <100 ,LS.
RESULTS
Analogous Mutations in the Putative Linker Domain. We began our functional comparison of NBF1 and NBF2 by examining the effects of mutations at glycine-551 in NBF1 and the corresponding residue in NBF2, glycine-1349. These residues were chosen because both loci are associated with naturally occurring CF mutations (14) , they lie within a putative linker sequence motif, and the glycine is absolutely conserved throughout the traffic ATPase family (6) . The effects of serine, aspartic acid, and alanine substitutions for glycine-551 and -1349 were compared, and the results are plotted in Fig. 2 as stimulated conductance (gcl) normalized to maximum stimulated gcl versus IBMX dose. As previously reported (18), G551S, a mutation associated with mild disease (34) , exhibited a moderate reduction in sensitivity (K1l2 = 1.1 mM IBMX) compared to wild-type (Kl2 = 0.3 mM). The analogous substitution in NBF2 (G1349S), although not identified in patients, produced a virtually identical reduction in sensitivity (K1l2 = 1.1 mM IBMX). G551D, associated with severe CF (35, 36) , and G1349D, also a CF mutation (37), both exhibited a dramatic reduction in sensitivity (K1l2 = 2. Physiology: Smit et al. mM IBMX). The alanine substitution in either NBF produced a moderate reduction in sensitivity, roughly equivalent to that observed with the serine substitutions.
NBF1/NBF2 Double Mutants. To explore further the relative contributions of the two domains, we measured the activation of Cl-currents in oocytes expressing the double mutants G551S/G1349S and G551D/G1349D. The combination of two serine substitutions had an additive effect; the double mutant was markedly less susceptible to activation than either of the singly substituted constructs (Fig. 3) . Similarly, the double aspartate substitution, compared to either single substitution, reduced the sensitivity to activation. Serine/aspartate double mutants were indistinguishable from the single aspartate constructs (data not shown). It should be noted that for the least sensitive mutants the dose-response never reached a plateau value, so that the sensitivity to activation for those constructs was, if anything, overestimated due to normalization to a submaximum conductance.
Substitutions in the ATP-Binding Pocket. To determine whether the functional homology between NBF1 and NBF2 extends beyond the putative linker region surrounding glycine-551 and -1349, the effects of mutations in the Walker A and B motifs were explored. For the purpose of comparison, one residue was chosen in each region; for Walker A, the highly conserved lysine (K464 and K1250) and for Walker B, the invariant aspartic acid (D572 and D1370). Fig. 4 shows the results obtained with constructs in which glutamine was substituted for the Walker A lysines. In NBF1 the substitution resulted in a moderate reduction in the sensitivity of CFTR to activation (K1l2 = 0.8 mM), roughly equivalent to that seen with G551S. The result of the substitution at the 1250 codon in NBF2 was very different. Here, the same substitution produced an increase in the sensitivity of Cl-conductance to activation over that observed with wild-type CFTR (K1l2 < 0.02 mM). Alanine and arginine substitutions at lysine-464 and -1250 were associated with sensitivities similar to those observed with the glutamine substitutions (K464A or K464R, Kil2 = 0.8 mM; K1250A or K1250R, K,12 < 0.02 mM). In some oocytes expressing constructs bearing mutations at residue 1250, a Cl-conductance was detected in the absence of forskolin and IBMX. This baseline conductance was subtracted in the computation of the activated conductance, so the apparent K1l2 for activation is probably an underestimate of sensitivity. response curves for these mutants show evidence of a small decline in Cl-conductance at the higher doses of IBMX (2-5 mM) . This may reflect a small degree of IBMX block of CFTR that becomes apparent when the channels are completely activated.
Substitutions for the Walker B aspartic acid also produced different results in the two NBFs. Fig. 5 shows the results obtained when asparagine was substituted for the aspartic acid at 572 (NBF1) or 1370 (NBF2). In NBF1, this substitution resulted in a dramatic reduction in sensitivity (K1l2 = 2.5 mM), roughly equivalent to that seen with AF508 (18) or G551D, whereas in NBF2, the identical substitution produced an increase in sensitivity to forskolin and IBMX (Kql2 = 0.02 mM).
Macroscopic Fig. 2 . 
DISCUSSION
Both NBF1 and NBF2 Are Required for Normal Activation of CFTR. The effects of mutating glycine-551 and -1349 in NBF1 and NBF2 on the sensitivity of C1-currents to activation by forskolin and IBMX provide strong evidence that both of these domains play a critical role in the transduction mechanism that produces Cl-channel activation in response to increases in cytosolic cAMP. Although the precise role of the NBFs in channel activation has not been established, the available evidence (19, (26) (27) (28) (29) can be accommodated by a kinetic model that envisions channel activation as requiring at least two events: (i) phosphorylation of one or more serine residues in the R domain in the presence of the catalytic subunit of protein kinase A and (ii) the binding and/or hydrolysis of ATP at one or both of the NBFs. Experiments utilizing detached patches from NIH 3T3 cells expressing wild-type CFTR showed that, after exposure to a phosphorylating environment, channel opening required the presence of a readily hydrolyzable analog of ATP (27) ; this observation prompted the speculation that ATP hydrolysis may provide free energy necessary to effect a conformational change that leads to the conducting state. Although the mechanism for the ATP effect remains obscure, the present results indicate that normal activation requires two functional NBFs. That substitutions for the invariant glycine in the putative linker region produce comparable effects in either NBF1 or NBF2 suggests that there is a basic similarity in the mechanism by which each NBF contributes to the activation of Cl-conductance, and is consistent with the observation that substitution in either ofthese regions can produce severe CF. Anderson and Welsh (28) found that in detached patches from transfected cells, mutation of the conserved glycine (G551S or G1349D) dramatically reduced the value of the open probability (PO) in the presence of PKA and MgATP. The requirement for two intact NBFs has been demonstrated for some other traffic ATPases, including the mammalian P-glycoprotein (38) and the bacterial protein UvrA (39) .
NBF1 and NBF2 Function Differently in Activation. In contrast to the symmetric effect of alterations in the putative linker regions of NBF1 and NBF2, substitutions in the presumed nucleotide-binding pockets produced markedly different effects. Substitutions for the conserved lysine in Walker A or the conserved aspartate in Walker B, when made in NBF1, produced a discernible reduction in the sensitivity of CFTR to activating conditions. In contrast, the analogous substitutions in NBF2 had the opposite effect, actually increasing sensitivity over that seen with wild-type CFTR. This striking difference suggests that, despite the fact that both NBFs are required for normal activation, they either function differently in the activation of CFTR or differ in their structural constraints on the transduction process. In detached patches from mouse mammary epithelial cells expressing CFTR, Anderson and Welsh (28) found that Walker A mutations in the putative nucleotide-binding pocket of either NBF1 or NBF2 increased the apparent Kl2 for the activation of phosphorylated CFTR by MgATP, as would be expected if the binding and/or hydrolysis of ATP were compromised. They also reported, however, that CFTR C1-channel activity was inhibited by ADP and that the inhibition was alleviated by Walker mutations in NBF2 but not by mutations in NBF1, suggesting that NBF2 could be the site of an inhibitory effect of ADP. One possibility, for example, is that the local concentration of ADP exerts a negative feedback control on CFTR activation. Of particular interest is the observation (28) that mutation of the Walker A lysine in NBF2 to methionine (K1250M) produced a 4-fold reduction in the apparent Kil2 for the activation of CFTR by ATP but also completely eliminated inhibition by 1 mM ADP. The observations reported here are consistent with the idea that modifications of the Walker motifs in NBF2 could increase sensitivity to activation by attenuating the inhibitory influence of ADP.
CFTR Activation: Phosphorylation and NBF Transduction Processes. To understand how NBF mutations could alter the sensitivity of CFTR to activation by cAMP, it is necessary to place the results of these experiments in the context of a kinetic model for the activation process, such as that shown in Fig. 6 . In this simplified scheme, activation requires phosphorylation of the R domain and the binding of ATP at the NBFs followed by a further transition of the phosphorylated, ATP-bound form of CFTR to the conducting (open) state. No assumption is made about the order of the first two events in this model, but the rapid activation and inactivation of phosphorylated CFTR by ATP in detached patches (27) suggest that phosphorylation followed by ATP binding is one mode of activation. The model is simplified in that it does not include explicitly multiple phosphorylated states (26, 29, 40, 41) , differential binding ofATP at the two NBFs, or inhibition by ADP. The model does provide, however, a basis for understanding how an alteration in the ATP-binding or transduction steps can change the kinetics of the dose-dependent activation of Cl-conductance by increasing concentrations of cAMP.
The steady-state solution for this kinetic scheme can be found in standard textbooks on enzyme kinetics (42) . A detailed exposition is beyond the scope of this paper, but several qualitative results are pertinent. In the context of the present experiments the parameter of interest is the apparent Kl2 for the activation of Cl-conductance as cAMP is increased. The most important result of the analysis is that the sequential nature of the reactions makes them intrinsically interdependent. That is, the apparent Kl2 for the activation of Cl-conductance by PKA will be a function of the kinetic constants for all of the intermediate reactions leading to the opening of the Cl-channel. For example, regardless of the order of events, a mutation that reduces the affinity ofthe NBFs for ATP, or renders the transduction step less likely, will result in an increase in the level of PKA required to achieve a half-maximal Cl-conductance. These effects occur because altering any single step in the reaction sequence affects the probability of finding the protein in its different states. For example, if the predominant order of reactions were phosphorylation followed by ATP binding, a defect in the latter step would reduce the rate of formation of the ATP bound form so that achieving half-maximal conductance would require an increased abundance of the phosphorylated form of CFTR. Likewise, for the reverse order, reduced efficacy of ATP binding would dictate that higher levels of PKA are required to overcome the reduced abundance of CFTR-ATP. Regardless of the preferred order of the reaction, or even if there is none, a defect in the ATP-binding step or the subsequent transduction process is expected to shift the IBMX dose-response curve to the right. Similarly, increased efficacy of the ATP-binding or transduction steps, such as that which could result from reduced inhibition by ADP, will shift the apparent Kil2 to the left.
The reactions leading to the activation of CFTR could exhibit a degree of interdependence beyond that required by simple mass balance if there were a preferred order for the process-e.g., if the rate of ATP binding was significant only for the phosphorylated form of CFTR, or if ATP binding increased the probability of phosphorylating specific sites on the R domain. The present experiments provide no evidence for such an additional degree of interdependence, but in view of the potential complexity of the gating process, which could involve multiple phosphorylated states of CFTR (40) and two NBFs that function differently in the activation process, this possibility merits serious consideration.
